Literature DB >> 23839208

Early resumption of physical activities leads to inferior clinical outcomes after matrix-based autologous chondrocyte implantation in the knee.

Thomas R Niethammer1, Peter E Müller, Elem Safi, Andreas Ficklscherer, Björn P Roßbach, Volkmar Jansson, Matthias F Pietschmann.   

Abstract

PURPOSE: Matrix-based autologous chondrocyte implantation is a well-established operation procedure for full cartilage defects. When to resume physical activity after matrix-based autologous chondrocyte implantation is controversial. Our hypothesis was that early resumption of physical activity leads to a worse clinical outcome after matrix-based autologous chondrocyte implantation in the knee two years post-operatively. Physical activity is defined as any kind of impact sport.
METHODS: Forty-four patients with cartilage defects of the knee were treated with matrix-based autologous chondrocyte implantation (Novocart3D). All patients were assessed preoperatively and after a period of 24 months with the University of California Los Angeles (UCLA) Activity score. The return to physical activities or sports after matrix-based autologous chondrocyte implantation was documented. Patients were evaluated using the International Knee Documentation Committee Knee Examination Form and visual analogue scale for pain after 6, 12 and 24 months.
RESULTS: Fifty-five percent showed an unchanged level of physical activity in the UCLA Activity score post-operatively. About 35% showed a lower level and 10% a higher level of physical activity. The average return to physical activities or sports after matrix-based autologous chondrocyte implantation procedure was 10.2 months. Patients with a later return of sports after 12 months showed significantly better clinical results after two years. In particular, patients who started practicing impact sport after 12 months post-operatively showed significantly better results.
CONCLUSION: Resuming physical activity including impact sports without waiting at least 12 months after the operation leads to inferior outcomes up to 24 months after matrix-based autologous chondrocyte implantation. LEVEL OF EVIDENCE: Level IV.

Entities:  

Mesh:

Year:  2013        PMID: 23839208     DOI: 10.1007/s00167-013-2583-z

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN: 0942-2056            Impact factor:   4.342


  42 in total

Review 1.  Surgical management of articular cartilage defects of the knee.

Authors:  A H Gomoll; J Farr; S D Gillogly; J Kercher; T Minas
Journal:  J Bone Joint Surg Am       Date:  2010-10-20       Impact factor: 5.284

2.  Mosaicplasty with autogenous talar autograft for osteochondral lesions of the talus after failed primary arthroscopic management: a prospective study with a 4-year follow-up.

Authors:  Peter Cornelius Kreuz; Matthias Steinwachs; Christoph Erggelet; Andreas Lahm; Philipp Henle; Philipp Niemeyer
Journal:  Am J Sports Med       Date:  2005-09-12       Impact factor: 6.202

Review 3.  Autologous chondrocyte implantation postoperative care and rehabilitation: science and practice.

Authors:  Karen Hambly; Vladimir Bobic; Barbara Wondrasch; Dieter Van Assche; Stefan Marlovits
Journal:  Am J Sports Med       Date:  2006-01-25       Impact factor: 6.202

4.  Characteristic complications after autologous chondrocyte implantation for cartilage defects of the knee joint.

Authors:  Philipp Niemeyer; Jan M Pestka; Peter C Kreuz; Christoph Erggelet; Hagen Schmal; Norbert P Suedkamp; Matthias Steinwachs
Journal:  Am J Sports Med       Date:  2008-09-18       Impact factor: 6.202

Review 5.  Activity vs. rest in the treatment of bone, soft tissue and joint injuries.

Authors:  J A Buckwalter
Journal:  Iowa Orthop J       Date:  1995

Review 6.  Rehabilitation after autologous chondrocyte implantation in athletes.

Authors:  Shane J Nho; Michael J Pensak; Daniel A Seigerman; Brian J Cole
Journal:  Clin Sports Med       Date:  2010-04       Impact factor: 2.182

Review 7.  Current treatment options for the restoration of articular cartilage.

Authors:  J E Gilbert
Journal:  Am J Knee Surg       Date:  1998

8.  Which is the best activity rating scale for patients undergoing total joint arthroplasty?

Authors:  Florian D Naal; Franco M Impellizzeri; Michael Leunig
Journal:  Clin Orthop Relat Res       Date:  2008-06-28       Impact factor: 4.176

Review 9.  [Indications and implementation of recommendations of the working group "Tissue Regeneration and Tissue Substitutes" for autologous chondrocyte transplantation (ACT)].

Authors:  P Behrens; U Bosch; J Bruns; C Erggelet; S A Esenwein; C Gaissmaier; T Krackhardt; J Löhnert; S Marlovits; N M Meenen; J Mollenhauer; S Nehrer; F U Niethard; U Nöth; C Perka; W Richter; D Schäfer; U Schneider; M Steinwachs; K Weise
Journal:  Z Orthop Ihre Grenzgeb       Date:  2004 Sep-Oct

Review 10.  Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects.

Authors:  E B Hunziker
Journal:  Osteoarthritis Cartilage       Date:  2002-06       Impact factor: 6.576

View more
  5 in total

1.  Revision surgery after third generation autologous chondrocyte implantation in the knee.

Authors:  Thomas R Niethammer; Thomas Niethammer; Siegfried Valentin; Andreas Ficklscherer; Mehmet F Gülecyüz; Mehmet Gülecyüz; Matthias F Pietschmann; Matthias Pietschmann; Peter E Müller; Peter Müller
Journal:  Int Orthop       Date:  2015-05-07       Impact factor: 3.075

Review 2.  Cell-based tissue engineering strategies used in the clinical repair of articular cartilage.

Authors:  Brian J Huang; Jerry C Hu; Kyriacos A Athanasiou
Journal:  Biomaterials       Date:  2016-04-26       Impact factor: 12.479

Review 3.  Autologous chondrocyte implantation: Is it likely to become a saviour of large-sized and full-thickness cartilage defect in young adult knee?

Authors:  Chi Zhang; You-Zhi Cai; Xiang-Jin Lin
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-05-19       Impact factor: 4.342

4.  Patient-oriented and performance-based outcomes after knee autologous chondrocyte implantation: a timeline for the first year of recovery.

Authors:  Jennifer S Howard; Carl G Mattacola; David R Mullineaux; Robert A English; Christian Lattermann
Journal:  J Sport Rehabil       Date:  2014-02-28       Impact factor: 1.931

5.  Patient-specific metal implants for focal chondral and osteochondral lesions in the knee; excellent clinical results at 2 years.

Authors:  Johannes Holz; Tim Spalding; Tarek Boutefnouchet; Pieter Emans; Karl Eriksson; Mats Brittberg; Lars Konradsen; Clemens Kösters; Peter Verdonk; Magnus Högström; Martin Lind
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2020-10-06       Impact factor: 4.114

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.